Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis.
Younossi, Zobair M
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis. [electronic resource] - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 03 2017 - 421-430.e6 p. digital
Publication Type: Journal Article
1542-7714
10.1016/j.cgh.2016.10.037 doi
Adult
Aged
Antiviral Agents--therapeutic use
Carbamates--therapeutic use
Clinical Trials, Phase III as Topic
Drug Therapy, Combination--methods
Female
Hepatitis C, Chronic--complications
Heterocyclic Compounds, 4 or More Rings--therapeutic use
Humans
Liver Cirrhosis
Male
Middle Aged
Patient Reported Outcome Measures
Ribavirin--therapeutic use
Sofosbuvir--therapeutic use
Surveys and Questionnaires
Sustained Virologic Response
Treatment Outcome
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis. [electronic resource] - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 03 2017 - 421-430.e6 p. digital
Publication Type: Journal Article
1542-7714
10.1016/j.cgh.2016.10.037 doi
Adult
Aged
Antiviral Agents--therapeutic use
Carbamates--therapeutic use
Clinical Trials, Phase III as Topic
Drug Therapy, Combination--methods
Female
Hepatitis C, Chronic--complications
Heterocyclic Compounds, 4 or More Rings--therapeutic use
Humans
Liver Cirrhosis
Male
Middle Aged
Patient Reported Outcome Measures
Ribavirin--therapeutic use
Sofosbuvir--therapeutic use
Surveys and Questionnaires
Sustained Virologic Response
Treatment Outcome